We're not growing
lettuce.
We produce pharmaceutical-grade bioactive crops where controlled environments unlock exponential value. Our portfolio spans saffron, medicinal plants, premium spices, gourmet crops, and essential oils.
Saffron
Crocus sativus
Saffron is the world's most precious spice and the cornerstone of our production strategy. We cultivate pharmaceutical-grade saffron in sterile, controlled environments where every gram achieves guaranteed crocin consistency.
Market Problem
- Iran's drought (2023-24) destroyed 35% of global supply
- Saffron prices swung 273% in 12 months ($523→$1,952/kg)
- 60% of 'premium' saffron on Amazon fails lab tests
- Open-field cultivation cannot control bioactive potency
- Pharmaceutical companies cannot plan costs against this volatility
Our Technology Advantage
- Sterile, dust-free cultivation eliminates contamination
- Controlled light spectrum optimizes crocin biosynthesis
- Pharmaceutical-grade batch certification (COA)
- HPLC-verified active compound content on every batch
- Zero pesticides, herbicides, or fungicides required
Why Saffron Works with CEA
- At ₹609/gram, modest yields generate substantial revenue
- Energy costs of controlled environment are economically viable
- Premium pricing justifies infrastructure investment
- No competition with commodity crop economics
- High switching cost once pharma buyers integrate our supply
🎯 Strategic Position
Saffron is our flagship crop and primary revenue driver. As pharmaceutical companies de-risk their supply chains from climate volatility, we provide the only scalable, certified source of standardized saffron worldwide. This creates a defensible moat through regulatory integration and supplier lock-in.
Medicinal Plants
Ashwagandha, Cordyceps & Beyond
Medicinal plants are the fastest-growing segment in global nutraceuticals. We cultivate pharmaceutical-grade medicinal botanicals with standardized bioactive potency for pharmaceutical, nutraceutical, and export markets.
Ashwagandha (Withania somnifera)
- Raw root price: ₹200–500/kg
- Extract value (KSM-66): ₹3,000–8,000/kg
- 10–20× value uplift vs. raw material
- N-restriction upregulates MVA pathway → withanolides ↑
- Standardised dosage requirement growing in pharma
- Represents 27.4% of India's $651M herbal exports to USA
Cordyceps Militaris
- Market size: $1.07–1.52 billion (2024)
- Growth rate: 12–15% CAGR
- Key bioactive: Cordycepin (anti-fatigue, immune support)
- Wild C. sinensis: $20,000–30,000/kg (endangered)
- Field cultivation impossible at commercial scale
- CEA is the ONLY viable production route (55–60% of global market)
Market Drivers
- 65% of urban Indian consumers seek herbal/natural products
- FSSAI 2023 amendments mandate ingredient traceability
- AYUSH Ministry: 1,650 products approved in 2023
- USA herbal supplement market: ~$13B in 2024
- Batch-to-batch potency variation (16× for ashwagandha) is regulatory liability
🎯 Strategic Position
Medicinal plants are experiencing explosive demand with zero verified domestic CEA supplier in India. We position ourselves as the trusted pharmaceutical-grade partner for nutraceutical manufacturers (Himalaya, Dabur, OmniActive) and pharma CDMOs requiring regulatory-compliant standardized APIs.
Premium Spices
Turmeric, Black Pepper, Cardamom
Premium spices with standardized bioactive content command exceptional prices in pharmaceutical extraction and gourmet markets. Our controlled cultivation maximizes potency while ensuring supply consistency.
Turmeric (Curcuma longa)
- Raw price: ₹50–100/kg
- 95% curcuminoid extract: ₹1,500–4,000/kg
- Potential uplift: 30–80× raw material value
- Controlled UV-B stress at 0.5–2.0 kJ/m²/day increases curcumin biosynthesis 15–45%
- Peer-reviewed validation (Journal of Photochemistry and Photobiology)
- Pharmaceutical-grade standardization eliminates batch variance
Black Pepper & Cardamom
- High-value premium crops supporting cash flow
- Standardized piperine and essential oil content
- Stable demand from spice processors and extractors
- Michelin-starred chef partnerships (gourmet channel)
- Luxury retail positioning for premium pricing
Bioactive Optimization
- Curcumin is regulated by light spectrum, temperature, nitrogen availability
- Our BIOMOD system applies environmental stress to upregulate secondary metabolites
- Not maximizing yield (kg/m²) but maximizing bioactive potency (mg-of-active/gram)
- Pharmaceutical buyers require HPLC-verified specifications on every batch
- Standardization enables 40× premium over generic commodity pricing
🎯 Strategic Position
Premium spices, particularly turmeric, leverage our biology-first optimization to achieve extraction premiums that justify CEA infrastructure. We position against the commodity spice market entirely—competing instead in pharmaceutical standardization and luxury gourmet channels where margin multiples make energy costs economically viable.
Gourmet Crops
Vanilla, Ginseng, Microgreens & Rare Botanicals
Premium gourmet crops serve luxury hospitality, high-end retail, and specialty ingredient markets. This channel generates rapid cash flow while providing crop diversification and market resilience.
Vanilla Orchids
- Volatile commodity pricing: $20→$600→$100/kg cycles
- Field cultivation: low yields, high risk to climate volatility
- CEA advantage: guaranteed freshness, consistency, and premium grading
- Target: luxury restaurants, high-end vanilla extract producers
- Supply chain stability attractive to professional chefs and food brands
Ginseng
- Premium market for fresh ginseng (higher value than dried)
- Our cultivation enables consistent harvesting schedules
- Professional kitchen partnerships (chef collaborations)
- Ginsenosides upregulated via temperature cycling protocols
- Direct-to-luxury-retail positioning maximizes margins
Microgreens & Specialty Botanicals
- Microgreens: rapid growth cycles (7–14 days), premium pricing
- Specialty herbs for plating and presentation: edible flowers, rare microgreens
- Zero pesticides, guaranteed food safety (sterile environment)
- Direct relationships with executive chefs and high-end restaurants
- Consistent supply enables menu planning and premium positioning
- HoReCa (Hotel/Restaurant/Catering) channel: 25% revenue target
🎯 Strategic Position
Gourmet crops serve as the rapid cash flow engine and market diversification buffer. By supplying Michelin-starred chefs and luxury hospitality, we establish brand reputation, generate quarterly revenue consistency, and de-risk portfolio concentration in pharmaceutical/nutraceutical channels. This segment validates our cultivation precision while building direct consumer brand awareness.
Essential Oils & Botanical Extracts
Aromatic & Therapeutic Compounds
Essential oils and botanical extracts are high-value derivatives of controlled cultivation. We optimize aromatic compound biosynthesis through precision environmental manipulation, delivering pharmaceutical-grade essential oils to cosmetic, fragrance, and nutraceutical markets.
Production Approach
- Essential oil-bearing plants: basil, oregano, thyme, lavender, mint species
- Controlled light spectrum, temperature, and humidity optimize terpene biosynthesis
- Harvest timing precision: captured at peak aromatic potency
- Zero pesticide contamination (sterile cultivation environment)
- GC-MS (Gas Chromatography-Mass Spectrometry) verification on every batch
- Standardized active compound profiles for cosmetic and pharmaceutical use
Market Segments
- Cosmetics & Fragrance: Standardized aromatic compounds for luxury skincare and perfumes
- Nutraceutical Extracts: Aromatic plant derivatives for supplements and functional foods
- Pharmaceutical APIs: Essential oil components as active pharmaceutical ingredients
- Aromatherapy: Therapeutic-grade essential oils for wellness markets
Bioactive Optimization
- Terpenes and volatile compounds regulated by light spectrum and temperature
- Stress protocols (controlled UV-A/B) increase essential oil yield and potency
- Phenolic compounds (thymol, carvacrol) upregulated through nitrogen management
- Harvest scheduling synchronized with peak aromatic biosynthesis cycles
- Post-harvest handling optimized for volatile compound preservation
- Batch-to-batch consistency enables cosmetic formulation and pharmaceutical registration
🎯 Strategic Position
Essential oils represent a high-margin extraction play within the $200B+ botanical extract market. Our precision cultivation optimizes terpene and phenolic compound biosynthesis, enabling premium positioning in cosmetic, fragrance, and pharmaceutical markets. Standardized GC-MS profiles provide regulatory compliance and switching costs once integrated into cosmetic formulations or pharmaceutical APIs.
Portfolio Overview
| Crop Category | Primary Crops | Price Point | Value Uplift | Market Opportunity |
|---|---|---|---|---|
| Saffron | Crocus sativus | ₹609/gram | Crocin consistency | $1.42B → $2.06B |
| Medicinal Plants | Ashwagandha, Cordyceps | Raw ₹200–500/kg | 10–20× extract premium | $11.78B → $51.83B (India) |
| Premium Spices | Turmeric, Black Pepper, Cardamom | Raw ₹50–100/kg | 30–80× extract uplift | $204.7B → $477B (2032) |
| Gourmet Crops | Vanilla, Ginseng, Microgreens | Premium retail pricing | 40–100% margin uplift | Michelin-starred hospitality |
| Essential Oils | Basil, Oregano, Lavender, Mint | Raw plant material | 10–100× extraction | $200B+ botanical extracts |